Clinical Trial

Impact of a Gluten-free Diet on Quality of Life in Patients With Axial Spondyloarthritis.

Study acronym: GlutenSPA
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Subclinical intestinal inflammation and gut dysbiosis have been reported in patients with spondyloarthritis (SpA). In common practice, rheumatologists are increasingly confronted with patients with inflammatory rheumatism who are on gluten-free diets (GFDs), despite the lack of reliable data from controlled studies. This study aims to determine the impact of a GFD on the quality of life of patients with axial SpA.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT04274374
Lead Sponsor University Hospital, Clermont-Ferrand
Collaborators: PANZANI, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Conditions Ankylosing Spondyloarthritis
Enrollment 200 participants
Start Date 2021-10-07
Primary Completion 2025-10 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2024-07-08